Related Experiment Video
Updated: Dec 30, 2025

07:25
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
13.6K
LATITUDE: A landmark trial for high-risk metastatic castration-sensitive prostate cancer: Final overall survival
1Department of Urology, AIIMS, Bhubaneshwar, Odisha, India.
Abstract
No abstract available in PubMed .

